Search
Close this search box.

Press Releases

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN […]

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from […]

Dr. N. Krishna Reddy appointed CEO and Dr. Sten Vermund inducted to ACCESS Health International’s Board of Directors

HYDERABAD, INDIA – Media OutReach Newswire – 4 January 2024 – ACCESS Health International, a globally recognized health systems think tank and advisory group, today announced two important leadership transitions. Dr. N. Krishna Reddy, who has been leading the operations as President across Asia, Middle East, and North Africa, has been appointed Chief Executive Officer. Concurrently, the organization […]